简介 :Sampatrilat (UK-81252) is a potent and orally active vasopeptidase inhibitor of ACE and neutral endopeptidase (NEP). Sampatrilat inhibits C-domain ACE (Ki=13.8 nM) 12.4-fold more potent than that for the N-domain (Ki=171.9 nM). Sampatrilat (UK-81252) can be used for the study of chronic heart failure and blood pressure regulation.
Catalog_No:HY-123348
Alternative_Names:UK-81252
产品一级分类:信号通路
二级分类:生命科学试剂
SMILES:OC([C@H](CNC([C@@H](NS(C)(=O)=O)CCCCN)=O)CC1(CCCC1)C(N[C@H](C(O)=O)CC2=CC=C(O)C=C2)=O)=O
Pathway:Metabolic Enzyme/Protease
Target:Angiotensin-converting Enzyme (ACE); Neprilysin
Research_Area:Inflammation/Immunology; Cardiovascular Disease
国际站:Sampatrilat